Abstract:Objective To screen out differentially expressed long non-coding RNAs (lncRNAs) and co-expression mRNAs and to perform the preliminary validation and functional prediction in bladder carcinoma.Methods Four pairs of carcinoma and para-carcinoma tissues were used for microarray assay to screen out the differentially expressed lncRNAs and co-expression mRNAs.Hierarchical clustering was performed to show lncRNA and mRNA expression patterns among samples.Five lncRNAs (RP11-359E19.2, AL928768.3, AC002519.6, RP11-79H23.3, AK021804) and four co-expression mRNAs (HRAS, VEGFA, ITGB1, DNMT3B) were chosen for verification of the microarray results by quantitative real-time PCR.Gene Ontology (GO) and KEGG pathway were used to analyze the biological function of co-expression mRNA.Results A total of 4 155 lncRNAs and 4 416 co-expression mRNAs were detected to be differentially expressed, among which, 2 045 lncRNAs were up-regulated and and 2 110 were down-regulated, meanwhile, 2 472 co-expression mRNAs were up-regulated and and 1944 were down-regulated, respectively.Totally 345 lncRNAs displayed fold change ≥10, including 127 up-regulated lncRNAs and 218 down-regulated lncRNAs.RP11-436F21.1 and H19 were the most up-regulated lncRNAs.Overview of coding gene profile showed that 75 mRNAs had fold change ≥10 (up: 57;down: 18).Comapred with the para-carcinoma tissues, the expression of RP11-359E19.2 in 5 lncRNAs was up-regulated, whereas AL928768.3, AC002519.6, RP11-79H23.3, and AK021804 expression was down-regulated in the bladder carcinoma tissues (all P<0.05).Meanwhile, the expression of HRAS, VEGFA, ITGB1, and DNMT3B in four co-expression mRNAs was all up-regulated (all P<0.05).The result was consistent with the microarray assay.GO assay showed that the up-regulated co-expression mRNAs mainly participate in the biological processes, such as cellular metabolic and mitotic cell cycle.Meanwhile, the down-regulated co-expression mRNAs mainly participate in the immune system process of stimulus response and immune response.KEGG pathway assay showed that 10 pathways were associated with the up-regulated or down-regulated mRNAs.Among the co-expression mRNAs, the enrichment of P53 signal pathway and bladder cancer was the highest, whereas in the down-regulated co-expression mRNAs, the cytokine-factor receptor interaction was the highest.Conclusions The differentially expressed LncRNAs and co-expression mRNAs are found and screened out in the bladder cancer.The specially expressed lncRNAs and and mRNAs could play important roles in the pathogenesis and development of bladder carcinoma, which might be new markers of bladder cancer.

Screening of characteristic biomolecules related to bladder cancer based on construction of ceRNA regulation network

To Construct a Cerna Regulatory Network As Prognostic Biomarkers for Bladder Cancer.

Comprehensive analysis of the lncRNA-miRNA-mRNA regulatory network for bladder cancer

Integrated Analysis of a Competing Endogenous RNA Network Reveals a Prognostic lncRNA Signature in Bladder Cancer

Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma

Competing Endogenous RNA Network Analysis Reveals Pivotal Cernas in Bladder Urothelial Carcinoma

Constructing the Cerna Regulatory Network and Combining Immune Cells to Evaluate Prognosis of Colon Cancer Patients

Identification of novel lncRNA prognostic biomarkers and their associated ceRNAs in bladder urothelial carcinoma

Whole transcriptome sequencing identifies a competitive endogenous RNA network that regulates the immunity of bladder cancer

The Construction and Analysis of Tumor-Infiltrating Immune Cells and ceRNA Networks in Bladder Cancer

Integrated analysis of lncRNA associated-competing endogenous RNAs as prognostic biomarkers in clear cell renal carcinoma.

Preliminary screening and functional prediction of long non-coding RNA and its co-expression mRNA in bladder carcinoma

Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma

Construction of Endometrial Carcinoma ceRNA Network and Screening of Key Genes Based on TCGA Database

The Construction and Analysis of Cerna Networks in Invasive Breast Cancer: a Study Based on the Cancer Genome Atlas.

Comprehensive Analysis of Differentially Expressed Profiles of Lncrnas and Circrnas with Associated Co-Expression and Cerna Networks in Bladder Carcinoma.

ceRNA Network and WGCNA Analyses of Differentially Expressed Genes in Cervical Cancer Tissues for Association with Survival of Patients

Cancer stem cell-specific expression profiles reveal emerging bladder cancer biomarkers and identify circRNA_103809 as an important regulator in bladder cancer

Integrated Analysis of Competing Endogenous RNA in Esophageal Carcinoma

Identification of hub genes in bladder transitional cell carcinoma through ceRNA network construction integrated with gene network analysis

Integrated genomic analyses of lung squamous cell carcinoma for identification of a possible competitive endogenous RNA network by means of TCGA datasets.